Table: RaQualia Pharma -Q1 group results

RaQualia Pharma

15/05/2020 07:00

May 15 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2020        Mar 31, 2019     Dec 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            123 mln             347 mln           2.13     
                 (-64.5 pct)         (-12.3 pct)      (+25.0 pct) 
  Operating     loss 273 mln        loss 104 mln        70 mln    
  Recurring     loss 267 mln         loss 95 mln        85 mln    
                                                     (+296.4 pct) 
  Net           loss 328 mln        loss 102 mln        13 mln    
                                                     (+161.6 pct) 
  EPS          loss 15.66 yen       loss 5.05 yen      0.67 yen   
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T